CE Mark Study for the Harpoon Medical Device in Poland

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 11, 2015

Primary Completion Date

February 8, 2018

Study Completion Date

November 16, 2022

Conditions
Mitral Valve RegurgitationMitral Valve ProlapseMitral Valve Insufficiency
Interventions
DEVICE

Harpoon Medical Device

It is expected that the Harpoon Medical transapical suturing device will be a valuable treatment alternative for patients suffering from mitral valve regurgitation because it can access the left ventricle with a small shaft or via a small valved introducer with a secure anchoring mechanism that can be deployed anywhere on the mitral valve leaflet.

Trial Locations (2)

31-202

John Paul II University Hospital, Krakow

04-628

Instytut of Kardiologii & Transplantology, Warsaw

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY